Healthcare provider profile · identity verified

Lisa Burgett, M.D.

Internal Medicine · WENATCHEE, WA · NPI 1891731139

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	490	224
Levothyroxine Sodium	Levothyroxine Sodium	477	201
Losartan Potassium	Losartan Potassium	363	151
Omeprazole	Omeprazole	361	162
Amlodipine Besylate	Amlodipine Besylate	343	145
Lisinopril	Lisinopril	289	124
Metoprolol Succinate	Metoprolol Succinate	220	100
Rosuvastatin Calcium	Rosuvastatin Calcium	204	94
Furosemide	Furosemide	189	93
Gabapentin	Gabapentin	177	71
Trazodone Hcl	Trazodone Hcl	166	69
Potassium Chloride	Potassium Chloride	142	58
Metformin Hcl Er	Metformin Hcl	138	58
Hydrochlorothiazide	Hydrochlorothiazide	128	54
Spironolactone	Spironolactone	123	47
Alendronate Sodium	Alendronate Sodium	120	56
Duloxetine Hcl	Duloxetine Hcl	114	38
Bupropion Xl	Bupropion Hcl	107	41
Pantoprazole Sodium	Pantoprazole Sodium	105	42
Escitalopram Oxalate	Escitalopram Oxalate	101	46
Irbesartan	Irbesartan	101	43
Sertraline Hcl	Sertraline Hcl	100	40
Carvedilol	Carvedilol	94	37
Simvastatin	Simvastatin	93	42
Jardiance	Empagliflozin	89	36
Famotidine	Famotidine	87	25
Albuterol Sulfate Hfa	Albuterol Sulfate	84	45
Montelukast Sodium	Montelukast Sodium	82	37
Eliquis	Apixaban	77	35
Tamsulosin Hcl	Tamsulosin Hcl	71	35
Trulicity	Dulaglutide	71	13
Ezetimibe	Ezetimibe	69	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	21
Citalopram Hbr	Citalopram Hydrobromide	68	27
Methocarbamol	Methocarbamol	67	27
Metformin Hcl	Metformin Hcl	66	25
Allopurinol	Allopurinol	65	26
Fluoxetine Hcl	Fluoxetine Hcl	61	29
Venlafaxine Hcl Er	Venlafaxine Hcl	60	26
Estradiol	Estradiol	58	32
Telmisartan	Telmisartan	58	20
Meloxicam	Meloxicam	56	28
Pravastatin Sodium	Pravastatin Sodium	55	20
Fluticasone Propionate	Fluticasone Propionate	54	27
Mirtazapine	Mirtazapine	53	18
Tramadol Hcl	Tramadol Hcl	53	19
Clopidogrel	Clopidogrel Bisulfate	52	19
Metoprolol Tartrate	Metoprolol Tartrate	50	22
Zolpidem Tartrate	Zolpidem Tartrate	49	13
Buspirone Hcl	Buspirone Hcl	48	19
Oxybutynin Chloride Er	Oxybutynin Chloride	48	18
Tizanidine Hcl	Tizanidine Hcl	48	25
Glipizide Er	Glipizide	45	19
Ozempic	Semaglutide	45	15
Donepezil Hcl	Donepezil Hcl	44	19
Pregabalin	Pregabalin	44	13
Pioglitazone Hcl	Pioglitazone Hcl	43	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	17
Clonazepam	Clonazepam	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	21
Celecoxib	Celecoxib	36	11
Atenolol	Atenolol	35	15
Myrbetriq	Mirabegron	35	13
Oxycodone Hcl	Oxycodone Hcl	35	12
Topiramate	Topiramate	34	12
Diclofenac Sodium	Diclofenac Sodium	30	14
Lovastatin	Lovastatin	30	13
Alprazolam	Alprazolam	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	11
Tolterodine Tartrate Er	Tolterodine Tartrate	29	14
Valacyclovir	Valacyclovir Hcl	29	22
Lorazepam	Lorazepam	28	15
Prednisone	Prednisone	28	16
Cephalexin	Cephalexin	27	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Dilt-Xr	Diltiazem Hcl	26	suppressed
Liothyronine Sodium	Liothyronine Sodium	26	suppressed
Nystatin	Nystatin	26	15
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	14
Digoxin	Digoxin	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Finasteride	Finasteride	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Primidone	Primidone	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Torsemide	Torsemide	20	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Nystop	Nystatin	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Nitroglycerin	Nitroglycerin	17	13
Acyclovir	Acyclovir	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Linzess	Linaclotide	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Aripiprazole	Aripiprazole	13	suppressed
Azithromycin	Azithromycin	13	13
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Metronidazole	Metronidazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error